David W. Osborne

Person

Santa Rosa, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 12,336,983
- Issue date Jun 24, 2025
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having antifungal properties
- Patent number 12,329,751
- Issue date Jun 17, 2025
- Arcutis Biotherapeutics, Inc.
- David Reuben Berk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having improved delivery and plasma...
- Patent number 12,310,956
- Issue date May 27, 2025
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 12,257,242
- Issue date Mar 25, 2025
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Roflumilast formulations with an improved pharmacokinetic profile
- Patent number 12,220,409
- Issue date Feb 11, 2025
- Arcutis Biotherapeutics, Inc.
- David Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions of roflumilast and solvents capable of...
- Patent number 12,144,802
- Issue date Nov 19, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Laureth-4 containing topical formulations
- Patent number 12,083,122
- Issue date Sep 10, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for deep dermal drug delivery
- Patent number 12,053,481
- Issue date Aug 6, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for reducing side effects from administration of phosphodies...
- Patent number 12,042,487
- Issue date Jul 23, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and formulation for improving roflumilast skin penetration l...
- Patent number 12,042,558
- Issue date Jul 23, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Roflumilast formulations with an improved pharmacokinetic profile
- Patent number 12,016,848
- Issue date Jun 25, 2024
- Arcutis Biotherapeutics, Inc.
- David Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Roflumilast formulations with an improved pharmacokinetic profile
- Patent number 12,011,437
- Issue date Jun 18, 2024
- Arcutis Biotherapeutics, Inc.
- David Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having improved delivery and plasma...
- Patent number 12,005,051
- Issue date Jun 11, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having improved delivery and plasma...
- Patent number 12,005,052
- Issue date Jun 11, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for reducing side effects from administration of phosphodies...
- Patent number 11,992,480
- Issue date May 28, 2024
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having improved delivery and plasma...
- Patent number 11,819,496
- Issue date Nov 21, 2023
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 11,793,796
- Issue date Oct 24, 2023
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Laureth-4 containing topical formulations
- Patent number 11,730,740
- Issue date Aug 22, 2023
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having antifungal properties
- Patent number 11,707,454
- Issue date Jul 25, 2023
- Arcutis Biotherapeutics, Inc.
- David Reuben Berk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for deep dermal drug delivery
- Patent number 11,628,177
- Issue date Apr 18, 2023
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions of roflumilast in aqueous blends of wat...
- Patent number 11,534,493
- Issue date Dec 27, 2022
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Topical roflumilast formulation having improved delivery and plasma...
- Patent number 11,129,818
- Issue date Sep 28, 2021
- Arcutis Biotherapeutics, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 10,940,142
- Issue date Mar 9, 2021
- Arcutis, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Skin penetration enhancing systems for polar drugs
- Patent number 10,441,530
- Issue date Oct 15, 2019
- AmDerma Pharmaceuticals, LLC
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 10,172,841
- Issue date Jan 8, 2019
- Arcutis, Inc.
- David W. Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Corticosteroid compositions
- Patent number 10,111,956
- Issue date Oct 30, 2018
- Tolmar, Inc.
- Robert Lathrop
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 10,105,354
- Issue date Oct 23, 2018
- Arcutis, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 9,907,788
- Issue date Mar 6, 2018
- Arcutis Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 9,895,359
- Issue date Feb 20, 2018
- Arcutis, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of crystal growth of roflumilast
- Patent number 9,884,050
- Issue date Feb 6, 2018
- Arcutis, Inc.
- David W. Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
- Publication number 20250235435
- Publication date Jul 24, 2025
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Application
PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND SOLVENTS CAPABLE OF...
- Publication number 20250144084
- Publication date May 8, 2025
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Roflumilast Formulations with an Improved Pharmacokinetic Profile
- Publication number 20250127767
- Publication date Apr 24, 2025
- ARCUTIS BIOTHERAPEUTICS, INC.
- David Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Application
METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...
- Publication number 20250049771
- Publication date Feb 13, 2025
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAURETH-4 CONTAINING TOPICAL FORMULATIONS
- Publication number 20240390380
- Publication date Nov 28, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
- Publication number 20240382502
- Publication date Nov 21, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC...
- Publication number 20240382504
- Publication date Nov 21, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...
- Publication number 20240374576
- Publication date Nov 14, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Roflumilast Formulations with an Improved Pharmacokinetic Profile
- Publication number 20240335435
- Publication date Oct 10, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David Osborne
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Application
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
- Publication number 20240335436
- Publication date Oct 10, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Application
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...
- Publication number 20240285595
- Publication date Aug 29, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC...
- Publication number 20240261308
- Publication date Aug 8, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Roflumilast Formulations with an Improved Pharmacokinetic Profile
- Publication number 20240216349
- Publication date Jul 4, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND SOLVENTS CAPABLE OF...
- Publication number 20240108609
- Publication date Apr 4, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...
- Publication number 20240024300
- Publication date Jan 25, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Roflumilast Formulations with an Improved Pharmacokinetic Profile
- Publication number 20240000760
- Publication date Jan 4, 2024
- ARCUTIS BIOTHERAPEUTICS, INC.
- David Osborne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
- Publication number 20230414511
- Publication date Dec 28, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
- Publication number 20230414589
- Publication date Dec 28, 2023
- ARCUTIS Biotherapeutics Inc.
- David W. OSBORNE
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Application
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...
- Publication number 20230364066
- Publication date Nov 16, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and Formulation for Improving Roflumilast Skin Penetration L...
- Publication number 20230346689
- Publication date Nov 2, 2023
- ARCUTIS Biotherapeutics Inc.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and Formulation for Improving Roflumilast Skin Penetration L...
- Publication number 20230346690
- Publication date Nov 2, 2023
- ARCUTIS Biotherapeutics Inc.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and Formulation for Improving Roflumilast Skin Penetration L...
- Publication number 20230338275
- Publication date Oct 26, 2023
- ARCUTIS Biotherapeutics Inc.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAURETH-4 CONTAINING TOPICAL FORMULATIONS
- Publication number 20230338383
- Publication date Oct 26, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
- Publication number 20230321057
- Publication date Oct 12, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David Reuben BERK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...
- Publication number 20230310397
- Publication date Oct 5, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...
- Publication number 20230310346
- Publication date Oct 5, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...
- Publication number 20230310345
- Publication date Oct 5, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...
- Publication number 20230285319
- Publication date Sep 14, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
- Publication number 20230226083
- Publication date Jul 20, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical Roflumilast Aerosol Foams
- Publication number 20230201177
- Publication date Jun 29, 2023
- ARCUTIS BIOTHERAPEUTICS, INC.
- David W. OSBORNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David W. Osborne

Person

Patents Grantslast 30 patents

Inhibition of crystal growth of roflumilast

Topical roflumilast formulation having antifungal properties

Topical roflumilast formulation having improved delivery and plasma...

Inhibition of crystal growth of roflumilast

Roflumilast formulations with an improved pharmacokinetic profile

Pharmaceutical compositions of roflumilast and solvents capable of...

Laureth-4 containing topical formulations

Compositions and methods for deep dermal drug delivery

Method for reducing side effects from administration of phosphodies...

Method and formulation for improving roflumilast skin penetration l...

Roflumilast formulations with an improved pharmacokinetic profile

Roflumilast formulations with an improved pharmacokinetic profile

Topical roflumilast formulation having improved delivery and plasma...

Topical roflumilast formulation having improved delivery and plasma...

Method for reducing side effects from administration of phosphodies...

Topical roflumilast formulation having improved delivery and plasma...

Inhibition of crystal growth of roflumilast

Laureth-4 containing topical formulations

Topical roflumilast formulation having antifungal properties

Compositions and methods for deep dermal drug delivery

Pharmaceutical compositions of roflumilast in aqueous blends of wat...

Topical roflumilast formulation having improved delivery and plasma...

Inhibition of crystal growth of roflumilast

Skin penetration enhancing systems for polar drugs

Inhibition of crystal growth of roflumilast

Corticosteroid compositions

Inhibition of crystal growth of roflumilast

Inhibition of crystal growth of roflumilast

Inhibition of crystal growth of roflumilast

Inhibition of crystal growth of roflumilast

Patents Applicationslast 30 patents

INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST

PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND SOLVENTS CAPABLE OF...

Roflumilast Formulations with an Improved Pharmacokinetic Profile

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...

LAURETH-4 CONTAINING TOPICAL FORMULATIONS

COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC...

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...

Roflumilast Formulations with an Improved Pharmacokinetic Profile

INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST

TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...

TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC...

Roflumilast Formulations with an Improved Pharmacokinetic Profile

PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND SOLVENTS CAPABLE OF...

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIES...

Roflumilast Formulations with an Improved Pharmacokinetic Profile

COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY

INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST

TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...

Method and Formulation for Improving Roflumilast Skin Penetration L...

Method and Formulation for Improving Roflumilast Skin Penetration L...

Method and Formulation for Improving Roflumilast Skin Penetration L...

LAURETH-4 CONTAINING TOPICAL FORMULATIONS

TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES

TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA...

SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...

SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...

SELF-PRESERVING TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DIET...

COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY

Topical Roflumilast Aerosol Foams